ARCHIVES

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

This article is from The Cancer Letter archive.

Vol. 22 No. 21 | May 24, 1996

Download PDF Visit The Full Archive

Related Articles

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

Attempt To Push NCI To Establish Diagnostic Coordinating Group Fails

July 5, 1974

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

Coordination, Funding Lacking In National Cancer Program: Report

October 7, 1994

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

Overall Cancer Mortality Rates Higher For Men Than Women

July 29, 2011